• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Drug Development - Articles and news items

CPhI logo

Join the epicenter of pharmaceutical & specialty chemical innovation

Supplier news / 21 March 2017 / CPhI

1 Pass. 3 Days. 44+ Sessions. 630+ Suppliers…

CPhI logo

Groundbreaking program lineup announced for CPhI North America’s Connect Conference

Supplier news / 21 March 2017 / CPhI

Hear from 55+ pharma industry leaders including, Merck, Eli Lilly, Pfizer, BASF, and Catalent, over three days of educational sessions…

digital issue #1 2017 formulation development drug delivery in-depth focus

Formulation Development & Drug Delivery In-Depth Focus 2017

Issue 1 2017, Supplements, Z Homepage promo / 22 February 2017 / European Pharmaceutical Review

Understanding the effect of API changes in pharmaceutical processing; Improving the consistency of MDI drug delivery; and Expert Views with DDF Summit and Eurofins Lancaster Laboratories…

Whitepaper: Accelerating development of enabled formulations for poorly soluble drugs

Whitepaper: Accelerating development of enabled formulations for poorly soluble drugs

Whitepapers, Z Homepage promo / 20 February 2017 / Quotient Clinical

In this whitepaper, Quotient Clinical discuss poorly soluble drugs and how they have developed an innovative approach to identify and overcome these solubility challenges…

How the implementation of Exalt™ for evaporative crystallisation studies improves stability and controlled delivery in drug development.

Supplier news / 12 July 2016 / Biopharma Group

Polymorph screening is an important stage of drug development. The aim is to identify the different crystalline structures or polymorphs that a drug may appropriate…

Coulter Partners

Coulter Partners has placed Dr Neil Brewis as Chief Scientific Officer and Michael Davies as VP Protein Science at F-star

Supplier news / 6 April 2016 / Coulter Partners

Coulter Partners has placed Dr Neil Brewis as Chief Scientific Officer and Michael Davies as VP Protein Science at F-star…

Future proofing - Part 2. PAT – Real Time Release Testing of Tablets

Future proofing – Part 2. PAT – Real time release testing of tablets

Supplier news / 4 April 2016 / Charles Ischi AG | Kraemer Elektronik

What requirements need to be met by a tablet testing system to guarantee a successful product release?

DiscoverX launches KILR™ assay platform for use in cancer immunotherapy drug development

Supplier news / 30 March 2016 / DiscoverX Corporation

DiscoverX Corporation has launched the KILR Retroparticles product line, providing scientists complete flexibility to develop a simple cytotoxicity assay in almost any cell line…

Future proofing - Part 1. Modularity and flexibility New LAB.line Tablet Hardness Testers

Future proofing – Part 1. Modularity and flexibility – New LAB.line tablet hardness testers

Supplier news / 29 February 2016 / Arwid Ischi, Charles Ischi AG | Kraemer Elektronik

What requirements need to be met by a tablet testing system to guarantee a successful product release? Is it dependable upon the testing system’s quality, speed, technology, flexibility or safety? Kraemer and Ischi explain…

High Pressure Homogenisation & the next generation of drug delivery: Liposomes

High Pressure Homogenisation & the next generation of drug delivery: Liposomes

Supplier news / 24 February 2016 / Biopharma Group

Liposomes are valued delivery vehicles for potent and efficacious active pharmaceuticals…

inABLE® technology helps unlock the secrets of cyclic peptides

inABLE® technology helps unlock the secrets of cyclic peptides

Supplier news / 17 February 2016 / Ingenza Laboratory

Ingenza is using its proprietary inABLE® technology to help develop a robust, versatile platform for the production of cyclic peptides for therapeutic use…

Quotient Clinical

Quotient Clinical celebrates its 100th RapidFACT® program

Supplier news / 11 February 2016 / Quotient Clinical

Quotient Clinical, the Translational Pharmaceutics® company, has announced that it has completed its 100th RapidFACT (Rapid Formulation development And Clinical Testing) program – a significant milestone in the growth of this service, which addresses drug R&D productivity issues…

 

Webinar: Understanding ISO Standards: ISO 14644-2:2015 Cleanroom MonitoringWATCH NOW
+ +